The Other Side: The Patients Hurt by Theranos' Botched Blood Tests

Sheri Ackert worried she might have a new tumor. Steve Hammons stopped taking his blood-thinning medication. Kimberly Toy emptied the pasta and sweets from her cupboards and said: “I can’t believe this happened.”

What they have in common are dubious test results from Theranos Inc. A review of regulatory records and interviews with patients shows the Palo Alto, Calif., company didn’t just burn investors who bought into its promise to revolutionize the world of blood testing. It also left a trail of agonized patients who had been drawn to Theranos by its claims of convenience, low cost and reliability.

Back to news